2019

Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2019, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.

Serious clinical events in HIV-positive persons with chronic kidney disease (CKD).
Ryom L, Lundgren JD, Law M, Kirk O, El-Sadr W, Bonnet F, Weber R, Fontas E, Monforte AD, Phillips A, Reiss P, de Wit S, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.
AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002331. [Epub ahead of print]

Longitudinal virological outcomes and factors associated with virological failure in behaviourally HIV-infected young adults on combination antiretroviral treatment in the Netherlands, 2000-2015
Weijsenfeld AM, Blokhuis C, Stuiver MM, Wit FWNM, Pajkrt D; ATHENA observational HIV cohort.
Medicine (Baltimore). 2019 Aug;98(32):e16357. doi: 10.1097/MD.0000000000016357.

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA
Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18. 

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis
Willemse S, Smit C, Sogni P, Sarcletti M, Uberti-Foppa C, Wittkop L, Raben D, D'Arminio Monforte A, Dabis F, Van Der Valk M; Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord.
J Viral Hepat. 2019 May 28. doi: 10.1111/jvh.13146. [Epub ahead of print]

Effect estimates in randomized trials and observational studies: comparing apples with apples
Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, van Sighem A, Reiss P, Bucher HC, Montoliu Giménez A, Jarrin I, Wittkop L, Meyer L, Perez-Hoyos S, Justice A, Neaton JD, Hernán MA; INSIGHT START Study Group and the HIV-CAUSAL Collaboration.
Am J Epidemiol. 2019 May 7. pii: kwz100. doi: 10.1093/aje/kwz100. [Epub ahead of print]

Piloting a surveillance system for HIV drug resistance in the European Union
van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK.
Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1800390.

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies
Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226-0. doi: 10.1016/j.jhep.2019.03.032. [Epub ahead of print]

Evaluating progress towards triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B in the Netherlands
Visser M, van der Ploeg CPB, Smit C, Hukkelhoven CWPM, Abbink F, van Benthem BHB, Op de Coul ELM.
BMC Public Health. 2019 Mar 29;19(1):353. doi: 10.1186/s12889-019-6668-6.

Predictive performance of cardiovascular disease risk prediction algorithms in people living with HIV
Van Zoest RA, Law M, Sabin CA, Vaartjes I, Van Der Valk M, Arends JE, Reiss P, Wit FW.
J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002069. [Epub ahead of print]

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.
Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18.

Challenges in modelling the proportion of undiagnosed HIV infections in Sweden
Andersson E, Nakagawa F, van Sighem A, Axelsson M, Phillips AN, Sönnerborg A, Albert J.
Euro Surveill. 2019;24(14):pii=1800203 

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies
Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226-0. doi: 10.1016/j.jhep.2019.03.032. [Epub ahead of print]

Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals
Tate JP, Sterne JAC, Justice AC; Veterans Aging Cohort Study (VACS) and the Antiretroviral Therapy Cohort Collaboration (ART-CC).
AIDS. 2019 Apr 1;33(5):903-912. doi: 10.1097/QAD.0000000000002140 

HIV-1 exposure and immune activation enhance sexual transmission of Hepatitis C virus by primary Langerhans cells
Nijmeijer BM, Sarrami-Forooshani R, Steba GS, Schreurs RRCE, Koekkoek SM, Molenkamp R, Schinkel J, Reis P. Siegen beek van Heukelom ML, van der Valk M, Ribeiro CMS, Geijtenbeek TBH
J Int AIDS Soc 2019;22 (3)J Int AIDS Soc. 2019; 22( 3):e25268

Cost-effectiveness of increased hiv testing among men who have sex with men in the netherlands
Reitsema M, Steffers L, Visser M, Heijne J, Hoek AJV, Loeff MSV, Van Sighem A, Van Benthem B, Wallinga J, Xiridou M, Mangen MJ.
AIDS. 2019 Mar 15. doi: 10.1097/QAD.0000000000002199. [Epub ahead of print]

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.
Stat Med. 2019 Mar 18. doi: 10.1002/sim.8120. [Epub ahead of print] 

Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: a retrospective cohort study
Weehuizen JM, Wensing AMJ, Mudrikova T, Wit FWNM, Hoepelman AIM.
Int J Antimicrob Agents. 2019 Mar 1. pii: S0924-8579(19)30048-2. doi: 10.1016/j.ijantimicag.2019.02.018. [Epub ahead of print]

Predicting virological response to HIV treatment over time: a tool for settings with different definitions of virological response
Revell AD, Wang D, Perez-Elias MJ, Wood R, Tempelman H, Clotet B, Reiss P, van Sighem AI, Alvarez-Uria G, Nelson M, Montaner JS, Lane HC, Larder BA.
J Acquir Immune Defic Syndr. 2019 Feb 14. doi: 10.1097/QAI.0000000000001989. [Epub ahead of print]

Incidence of a first thrombotic event in people with HIV in the Netherlands: a retrospective cohort study
Borjas Howard JF, Rokx C, Smit C, Wit FWNM, Pieterman ED, Meijer K, Rijnders B, Bierman WFW, Vladimir Tichelaar YIG, on behalf of ATHENA observational HIV cohort investigators
The Lancet HIV, published online February 15 2019; DOI:https://doi.org/10.1016/S2352-3018(18)30333-3

Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM
Newsum AM, Kooij KW, Boyd A, Smit C, Wit FWNM, van der Meer JTM, Prins M, Reiss P, van der Valk M; MOSAIC study group, ATHENA observational HIV cohort and NVHB-SHM hepatitis working group.
AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002138. [Epub ahead of print]

Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands
Toxopeus DCM, Pell CL, Westrhenen NB, Smit C, Wit FWNM, Ondoa P, Reiss P, Boender TS.
AIDS Care. 2019 Jan 2:1-8. doi: 10.1080/09540121.2018.1563280. [Epub ahead of print]

Incidence of a first thrombotic event in people with HIV in the Netherlands: a retrospective cohort study
Borjas Howard JF, Rokx C, Smit C, Wit FWNM, Pieterman ED, Meijer K, Rijnders B, Bierman WFW, Vladimir Tichelaar YIG, on behalf of ATHENA observational HIV cohort investigators
The Lancet HIV, published online February 15 2019; DOI:https://doi.org/10.1016/S2352-3018(18)30333-3

Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM
Newsum AM, Kooij KW, Boyd A, Smit C, Wit FWNM, van der Meer JTM, Prins M, Reiss P, van der Valk M; MOSAIC study group, ATHENA observational HIV cohort and NVHB-SHM hepatitis working group.
AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002138. [Epub ahead of print]

Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands
Toxopeus DCM, Pell CL, Westrhenen NB, Smit C, Wit FWNM, Ondoa P, Reiss P, Boender TS.
AIDS Care. 2019 Jan 2:1-8. doi: 10.1080/09540121.2018.1563280. [Epub ahead of print]